Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam.
Shikuma CM, Le T, Phuong TV, Chew GM, Nguyen VVC, Vo TL, Siriwardhana C, Chow D, Ghukasyan H, Limpruttidham N, Premeaux T, Gangcuangco LM, Paul R, Ndhlovu LC.
Shikuma CM, et al. Among authors: chew gm.
AIDS Res Hum Retroviruses. 2022 Jun;38(6):441-450. doi: 10.1089/AID.2021.0076. Epub 2022 Jan 13.
AIDS Res Hum Retroviruses. 2022.
PMID: 34861767
Free PMC article.
Clinical Trial.